206
Participants
Start Date
April 29, 2020
Primary Completion Date
July 3, 2020
Study Completion Date
August 3, 2020
Levilimab
Levilimab 324 mg
Placebo
Placebo
"State Budgetary Healthcare Institution Kaluga region Kaluga Regional Clinical Hospital", Kaluga
"State Budget Institution of the Republic of Dagestan Republican Clinical Hospital", Makhachkala
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow
City Clinical Hospital No. 40 of the Department of Health of the city of Moscow, Moscow
City Clinical Hospital No.52, Moscow
City Clinical Hospital № 15 named. O.M. Filatov, Moscow
City Clinical Hospital №1 named after N.I. Pirogov, Moscow City Health Department, Moscow
"Federal State Budgetary Institution Central Clinical Hospital with Clinic, Office of the President of the Russian Federation", Moscow
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow
Pirogov Russian National Research Medical University, Moscow
Railway clinical hospital named after N.A. Semashko, Moscow
Almazov National Medical Research Centre, Saint Petersburg
Clinical Infectious Disease Hospital named after S.P. Botkin, Saint Petersburg
North-western State Medical University named after I.I.Mechnikov, Saint Petersburg
"Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Healthcare of the Russian Federation", Ufa
"Federal State Budgetary Educational Institution of Higher Education North Ossetian State Medical Academy of the Ministry of Health of the Russian Federation (FSBEI HE SOGMA of the Ministry of Health of Russia)", Vladikavkaz
Lead Sponsor
Biocad
INDUSTRY